SCOPUS 정보 검색 플랫폼

Canadian Journal of Clinical Pharmacology

Volumn 7, Issue 2, 2000, Pages 97-101

New drug approval times and 'therapeutic potential' in Canada, Australia, Sweden and the United States during the period 1992 to 1998

(2) Rawson, Nigel S B a,c Kaitin, Kenneth I b

a MEMORIAL UNIVERSITY OF NEWFOUNDLAND (Canada)

b TUFTS UNIVERSITY SCHOOL OF MEDICINE (United States)

c MEMORIAL UNIVERSITY OF NEWFOUNDLAND (Canada)

Author keywords

Australia; Canada; Drug approval; Drug lag; Sweden; Therapeutic potential; United States

Indexed keywords

ACARBOSE; ADAPALENE; ADENOSINE; AMIFOSTINE; ATORVASTATIN; CARVEDILOL; CERIVASTATIN; CLADRIBINE; CLOPIDOGREL; DESFLURANE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DOCETAXEL; DOLASETRON MESILATE; FINASTERIDE; FLUINDOSTATIN; GABAPENTIN; GEMCITABINE; GRANISETRON; INDINAVIR; IRBESARTAN; ITRACONAZOLE; LAMIVUDINE; LAMOTRIGINE; MEROPENEM; NARATRIPTAN; NELFINAVIR; NEW DRUG; OLANZAPINE; UNINDEXED DRUG;

ARTICLE; AUSTRALIA; CANADA; DRUG APPROVAL; DRUG MARKETING; HEALTH CARE POLICY; HUMAN; SWEDEN; UNITED STATES;

EID: 0033827429 PISSN: 1198581X EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (9)

References (25)

1
- 85041249984
- Report of the Commission of Inquiry on the Pharmaceutical Industry. Ottawa: Supply and Services Canada
- (1985)
- Eastman, H.C.¹

2
- 85041276589
- Nielsen Task Force. Health and Sports Program: a study team report to the Task Force on Program Review. Ottawa: Supply and Services Canada
- (1985) , pp. 95-109

3
- 85041276844
- Auditor General of Canada. Drug Regulation. Report to the House of Commons, fiscal year ending 31 March 1987. Ottawa: Supply and Services Canada
- (1987)

4
- 85041276347
- Working Group on Drug Submission Review. Memorandum to the Minister (the Stein Report). Ottawa: Health and Welfare Canada
- (1987)

5
- 85041268660
- Program Evaluation Study of the Drug Safety, Quality and Efficacy Program. Ottawa: Health and Welfare Canada
- (1989)
- Overstreet, R.E.¹ Berger, J.² Turriff, C.³

6
- 85041271912
- Working in partnerships...Drug review for the future. Ottawa: Health and Welfare Canada
- (1992)
- Gagnon, D.¹

7
- 0003270309
- Feds slagged for not approving AIDS drug
- (1998) Medical Post , pp. 54

8
- 0002467674
- AIDS activists condemn slow drug-approval process
- (1998) Globe and Mail
- Picard, A.¹

9
- 33847542243
- Canada needs faster drug approvals, fewer addict prosecutions, AIDS society says
- (1998) Globe and Mail

10
- 0001801897
- First to start, last to finish: Approvals track record is poor
- (1999) Medical Post , pp. 12
- Pole, K.¹

11
- 85041268762
- Your government on drugs
- (1998) Globe and Mail

12
- 85041270086
- Canadian Viagra sales possible by March
- (1998) National Post
- Cherney, E.¹

13
- 0026474552
- A comparison of regulatory approval times for new chemical entities in Australia, Canada, Sweden, the United Kingdom and the United States
- (1992) J Clin Pharmacol , vol.32 , pp. 889-896
- Pieterson, E.A.¹

14
- 0030951929
- The Prescription Drug User Fee Act of 1992 and the new drug development process
- (1997) Am J Ther , vol.4 , pp. 167-172
- Kaitin, K.I.¹

15
- 0034045314
- The new drug approvals of 1996, 1997 and 1998: Drug development trends in the user fee era
- (2000) Drug Inform J , vol.34 , pp. 1-14
- Kaitin, K.I.¹ Healy, E.M.²

16
- 0000320998
- The FDA maintains rigorous safety standards
- (1999) Med Crossfire , vol.1 , pp. 56-58
- Woodcock, J.¹

17
- 0031773169
- Drug review in Canada: A comparison with Australia, Sweden, the United Kingdom and the United States
- (1998) Drug Inform J , vol.32 , pp. 1133-1141
- Rawson, N.S.B.¹ Kaitin, K.I.² Thomas, K.E.³ Perry, G.⁴

18
- 0034701075
- Time required for approval of new drugs in Canada, Australia, Sweden, the United Kingdom and the United States in 1996-1998
- (2000) Can Med Assoc J , vol.162 , pp. 501-504
- Rawson, N.S.B.¹

19
- 0008060347
- Practical Nonparametric Statistics. New York: Wiley
- (1971) , pp. 264-270
- Conover, W.J.¹

20
- 85041245154
- Priority review policy. Manual of policies and procedures, MAPP 6020.3. Rockville: Center for Drug Evaluation and Research

21
- 85041273302
- Therapeutic Products Directorate. Policy Issues from the Therapeutic Products Directorate: Management of Drug Submissions. Ottawa: Health Canada

22
- 85041248991
- Therapeutic Products Program. Annual Drug Submission Performance Report, 1998. Ottawa: Health Canada

23
- 85041257406
- A Question of Balance: Report on the Future of Drug Evaluation in Australia. Canberra: Minister for Aged, Family and Health Services
- Baume, P.¹

24
- 0032740491
- The European Agency for the Evaluation of Medicinal Products' centralized procedure for product approval: Current status
- (1999) Drug Inform J , vol.33 , pp. 969-978
- Healy, E.M.¹ Kaitin, K.I.²

25
- 85041267010
- Drug Submission Evaluation: International Comparison of Performance Standards and Performance. Ottawa: Drugs Directorate, Health Canada
- Stroud, R.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.